Teva Pharmaceuticals
TEVA
TEVA
685 hedge funds and large institutions have $18.6B invested in Teva Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 256 increasing their positions, 254 reducing their positions, and 113 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
26% less funds holding in top 10
Funds holding in top 10: 27 → 20 (-7)
32% less first-time investments, than exits
New positions opened: 77 | Existing positions closed: 113
52% less call options, than puts
Call options by funds: $303M | Put options by funds: $630M
Holders
685
Holding in Top 10
20
Calls
$303M
Puts
$630M
Top Buyers
| 1 | +$844M | |
| 2 | +$727M | |
| 3 | +$501M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$250M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$186M |
Top Sellers
| 1 | -$843M | |
| 2 | -$325M | |
| 3 | -$158M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$136M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$136M |